Upgrade to SI Premium - Free Trial

Valeant (VRX) Derm NRx Down 6% Week-Over-Week - RBC Capital

April 8, 2016 10:21 AM
RBC Capital analyst Douglas Miehm notes Valeant Pharmaceuticals (NYSE: VRX) Derm NRx (largely Walgreens) decreased 6.0% week over week. Meanwhile ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments FDA Short Sales Trader Talk

Next Articles